Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Examining the causal association between 25-hydroxyvitamin D and caries in children and adults: a two-sample Mendelian randomization approach. | Wellcome Open Res | 2020 | 34386609 | PubTator, text mining | PubMed |
| Ketamine Use for Cancer and Chronic Pain Management. | Front Pharmacol | 2020 | 33708116 | PubTator, text mining | PubMed |
| Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy. | Front Pediatr | 2020 | 33553069 | PubTator, text mining | PubMed |
| The therapeutic role of Cannabidiol in mental health: a systematic review. | J Cannabis Res | 2020 | 33526132 | PubTator, text mining | PubMed |
| Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity. | ACS Omega | 2020 | 33376898 | PubTator, text mining | PubMed |
| How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing? | Front Genet | 2020 | 33363564 | PubTator, text mining | PubMed |
| Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells. | Front Pharmacol | 2020 | 33343369 | PubTator, text mining | PubMed |
| Ertugliflozin in the treatment of type 2 diabetes mellitus. | Drugs Context | 2020 | 33293984 | PubTator, text mining | PubMed |
| A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder. | J Transl Genet Genom | 2020 | 33274315 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old. | J Pain Res | 2020 | 33262645 | PubTator, text mining | PubMed |
| Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line. | Cells | 2020 | 33260628 | PubTator, text mining | PubMed |
| Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2020 | 33256802 | PubTator, text mining | PubMed |
| Dataset of potential Rhizoma Polygonati compound-druggable targets and partial pharmacokinetics for treatment of COVID-19. | Data Brief | 2020 | 33251300 | PubTator, text mining | PubMed |
| Cannabidiol in epilepsy: The indications and beyond. | Ment Health Clin | 2020 | 33224689 | PubTator, text mining | PubMed |
| The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes. | Cancers (Basel) | 2020 | 33202946 | PubTator, text mining | PubMed |
| Pharmacogenomics for Primary Care: An Overview. | Genes (Basel) | 2020 | 33198260 | PubTator, text mining | PubMed |
| Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19. | Front Pharmacol | 2020 | 33192503 | PubTator, text mining | PubMed |
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen. | Pharmaceutics | 2020 | 33147873 | PubTator, text mining | PubMed |
| New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs). | Molecules | 2020 | 33147810 | PubTator, text mining | PubMed |
| A Review of the Important Role of CYP2D6 in Pharmacogenomics. | Genes (Basel) | 2020 | 33143137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=37